Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-23

Clinical Trial Update: Trial of Dextromethorphan in Rett Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial of dextromethorphan in Rett syndrome was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextromethorphan (dextromethorphan)

Snippet

Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | Conditions: Rett Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2014-04-23